Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06420349
What this trial is testing

NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma

Who this might be right for
Advanced CholangiocarcinomaMetastatic CholangiocarcinomaRefractory Cholangiocarcinoma+4 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT02042443
What this trial is testing

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Who this might be right for
Adult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT03907852
What this trial is testing

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesothelioma, MalignantMesothelioma; Pleura+8 more
TCR2 Therapeutics 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06567600
What this trial is testing

Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaChemotherapy EffectImmunotherapy
Third Affiliated Hospital, Sun Yat-Sen University 43
Very early researchLooking for participantsNCT06583993
What this trial is testing

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Changzheng Hospital 9
Not applicableNot Yet RecruitingNCT07558304
What this trial is testing

Suprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial)

Who this might be right for
CholangiocarcinomaBile Duct NeoplasmsMalignant Biliary Obstruction
Hospital de Clinicas de Porto Alegre 84
Early research (Phase 1)Study completedNCT03219268
What this trial is testing

MGD013 in Patients With Unresectable or Metastatic Neoplasms

Who this might be right for
Advanced Solid TumorsHematologic NeoplasmsOvarian Cancer+7 more
MacroGenics 277
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Not applicableUnknownNCT06369480
What this trial is testing

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Rigshospitalet, Denmark 2,000
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT00350961
What this trial is testing

Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Rigshospitalet, Denmark 39
Testing effectiveness (Phase 2)Study completedNCT00553332
What this trial is testing

Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver and Intrahepatic Biliary Tract CancerRecurrent Extrahepatic Bile Duct CancerUnresectable Extrahepatic Bile Duct Cancer
National Cancer Institute (NCI) 29
Not applicableLooking for participantsNCT06899152
What this trial is testing

HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer

Who this might be right for
Liver CancerHepatocellular CarcinomaHepatocellular Cancer+2 more
Montefiore Medical Center 40
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Very early researchWithdrawnNCT06572189
What this trial is testing

The Safety and Efficacy of CD-801 in Patients With Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Changzheng Hospital
Testing effectiveness (Phase 2)UnknownNCT05835245
What this trial is testing

Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free)

Who this might be right for
Advanced Intrahepatic Cholangiocarcinoma
Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT01766219
What this trial is testing

CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+6 more
Wake Forest University Health Sciences 17
Large-scale testing (Phase 3)WithdrawnNCT03081039
What this trial is testing

Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
University of Louisville
Testing effectiveness (Phase 2)Ended earlyNCT03316222
What this trial is testing

Study of GNS561 in Patients With Liver Cancer

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinoma, Intrahepatic
Genoscience Pharma 50
Next Page